Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-03-02 @ 10:34 PM
Study NCT ID:
NCT06498518
Status:
WITHDRAWN
Last Update Posted:
2025-07-11
First Post:
2024-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2024-07-02
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-08
Last Update Post Date:
2025-07-11
Last Update Post Date Type:
ACTUAL